NED Medical, Inc. — SEC Form D Filing
NED Medical, Inc. filed an SEC Form D on February 19, 2026, reporting $8.00M raised in Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- February 19, 2026
- Amount reported
- $8.00M
- Round stage
- Seed
- Industry
- Health Care
- Website
- https://nedmedical.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Liver cancer has a low survival rate and current treatments like radioembolization provide limited outcomes for patients.
Solution
NED Medical offers CombiSphere, a proprietary radioembolization therapy designed to enhance treatment options and improve patient outcomes.
Why now
With rising liver cancer diagnoses and stagnant survival rates, innovative treatment options are urgently needed.
Verdict
Investors backed NED Medical at this moment due to an urgent need for improved liver cancer treatments, betting implicitly on the potential success of CombiSphere amid stagnant survival rates. This cleared because there was a clear market need supported by innovation, not because competitors weren't already established. However, the durability of this bet is limited by high regulatory risks and the uncertain adoption of new therapies in traditional hospital settings.
Source: SEC EDGAR Form D filing